Tisch MS News

Tisch MSRCNY Completes Treatment Phase of FDA-Approved Phase I Stem Cell Trial for MS

Tisch MSRCNY is excited to announce that as of September 14, 2016, all 20 patients in our FDA approved Phase I stem cell clinical trial have received their final treatment! Results will be analyzed and presented at our annual patient symposium on October 16th, 2016 at the New York Hilton Midtown. We will submit for publication in leading scientific journals in the near future!

Tisch MSRCNY Returns from San Francisco and the International Society for Stem Cell Research 2016 Annual Meeting

At the heart of the stem cell community is the ISSCR Annual Meeting - a place where breakthrough science, global collaboration, and researchers across the breath of the field come together. The ISSCR Annual Meeting offers the best opportunity to collaborate with leaders and peers from around the world to fully realize the promise of our field in therapies, treatments, and clinical advances. Dr. Violaine Harris (pictured) and Dr. Saud A. Sadiq from Tisch MSRCNY presented their work June 22nd - 25th at this important conference.

Join Team Tisch MS Today!

Do you walk, jog, swim, dance, run etc.? Are you an iron woman or iron man? Join Team Tisch MS and support the Center! Create an account with Everyday Hero at: http://everydayhero.com/us. For more information send us an email at development@tischms.org.

Saud A. Sadiq, MD, FAAN - Director and Chief Research Scientist

Saud A. Sadiq, MD, FAAN is the Director and Chief Research Scientist of the Tisch MS Research Center of New York. Dr. Sadiq is a board-certified neurologist with residency training in Internal Medicine in England, and in Neurology at the University of Texas, where he was elected to the Alpha Omega Alpha Honor Medical Society. From 1988-91, he trained as a research fellow funded by a Dana Fellowship award and an MDA Fellowship in Neuroimmunology at Columbia University in New York.

Register Here for the Tisch MSRCNY 2016 MS Patient Symposium

Powered by Eventbrite

Stem Cells Show Reversal of Disability in Multiple Sclerosis at the American Academy of Neurology (AAN) 2016 Annual Meeting

For Immediate Release:              MS Patients Take Steps without Cane as Damage is Repaired

AAN 2016 Annual Meeting Presentation: FDA Phase I Stem Cell Trial Data Slides

Tisch Multiple Sclerosis Research Center of New York is pleased to share Dr. Saud A. Sadiq's slides presented at the American Academy of Neurology's (AAN) 68TH Annual Meeting in Vancouver, Canada. Neurologists from all over the world gathered to hear the exciting data presented on the Center's FDA- approved stem cell clinical trial for MS. Blitz Presentation.pdf

Dr. Saud A. Sadiq speaks about the Tisch MSRCNY Stem Cell Trial on NY1 during National MS Awareness Month

See the full interview at NY1 here: http://bit.ly/1RoY0x1.

Dr. Sadiq Interviewed On The Joan Hamburg Show

Director and Chief Research Scientist of the Tisch MS Research Center of New York,  Dr. Saud A. Sadiq, talks with Joan Hamburg  about MS and our Phase II stem cell trial. Listen to the full interview here: http://bit.ly/1QGIeMa.

Update: Phase II Stem Cell Trial

We are proud to announce Tisch Multiple Sclerosis Research Center of New York is teaming up with the Judith Jaffe Multiple Sclerosis Center at Weill Cornell Medical College for our Phase II stem cell trial for MS.

Pages

Subscribe to MSRCNY News

521 West 57 St., 4th Flr, NY NY 10019 | ©2016 Tisch MS All rights reserved.

This is the website of the Tisch MS Research Center of New York, a non-profit, independent, multiple sclerosis research laboratory, and not a  medical practice. CLICK HERE to be directed to our clinical affiliate, the International Multiple Sclerosis Management Practice.